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In addition to being the primary organ involved in redox cycling, the liver is one of the most highly innervated tissues in
mammals. The interaction between hepatocytes and sympathetic, parasympathetic, and peptidergic nerve fibers through a variety
of neurotransmitters and signaling pathways is recognized as being important in the regulation of hepatocyte function, liver
regeneration, and hepatic fibrosis. However, less is known regarding the role of the sympathetic nervous system (SNS) in
modulating the hepatic response to oxidative stress. Our aim was to investigate the role of the SNS in healthy and oxidatively
stressed liver parenchyma. Mice treated with 6-hydroxydopamine hydrobromide were used to realize chemical sympathectomy.
Carbon tetrachloride (CCl
4
) injection was used to induce oxidative liver injury. Sympathectomized animals were protected
from CCl
4
induced hepatic lipid peroxidation-mediated cytotoxicity and genotoxicity as assessed by 4-hydroxy-2-nonenal levels,
morphological features of cell damage, andDNAoxidative damage. Furthermore, sympathectomymodulated hepatic inflammatory
response induced by CCl
4
-mediated lipid peroxidation. CCl
4
induced lipid peroxidation and hepatotoxicity were suppressed by
administration of an 𝛼-adrenergic antagonist. We conclude that the SNS provides a permissive microenvironment for hepatic
oxidative stress indicating the possibility that targeting the hepatic 𝛼-adrenergic signaling could be a viable strategy for improving
outcomes in patients with acute hepatic injury.
1. Introduction
The liver is one of the most highly innervated tissues in
mammals. The interaction between hepatocytes and sympa-
thetic, parasympathetic, and peptidergic nerve fibers through
a variety of neurotransmitters and signaling pathways is
recognized as being important in the regulation of hepatocyte
function and hepatic response to injury [1]. Studies of
hepatic architecture identify adrenergic nerve fibers extend-
ing from perivascular plexus in the portal space into the
lobule [2]. Sympathetic nervous system (SNS) transmission
to hepatocytes occurs through release of norepinephrine and
epinephrine as neurotransmitters from intrahepatic nerve
endings and by delivery as hormones from adrenal glands.
In addition to being important for a range of functions
such as regulating hepatic circulation, metabolism, and bile
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formation the SNS is also known to modulate both liver
regeneration and fibrosis [3–5].
Potential associations between the SNS and oxidative
stress are indicated from previous studies. Hepatic mono-
amine oxidases catalyze oxidative deamination of catechol-
amines such as norepinephrine and epinephrine. During this
process hydrogen peroxide (H
2
O
2
) is generated and further
converted to water by glutathione peroxidase during which
glutathione is utilized [6]. Thus, oxidation of catecholamines
is a source of reactive oxygen species (ROS) [7]. Long-term
elevation of epinephrine can deplete hepatic glutathione as
epinephrine both decreases the rate of glutathione synthesis
in the liver and increases the rate of glutathione release from
the liver whilst decreasing the rate of recycling of oxidized
glutathione [8–10]. Similarly, epinephrine stimulates H
2
O
2
production via cyclic 3󸀠-5󸀠-adenosine monophosphates in
macrophages [11]. Intense physical work is known to increase
sympathetic activity and ROS production in the rodent heart
[12].The knowledge that𝛽-adrenergic stimulation is themain
driver of ROS generation in mitochondria [13] has indicated
the use of 𝛽-adrenergic receptor blockers to reduce oxidative
stress in cardiac failure [14, 15].
Although these studies clearly suggest a role for cate-
cholamines in themodulation of oxidative stress, whether the
SNS affects oxidative stress in the liver has yet to be estab-
lished. CCl
4
is a classic model compound for inducing free
radical damage in the liver [16, 17], beingmetabolized to form
trichloromethyl and trichloromethyl peroxy radicals which
covalently bind to proteins, lipids, and nucleic acids to initiate
lipid peroxidation, generate 4-hydroxy-2-nonenal (4-HNE),
and thus induce liver damage [17]. This model is also useful
for characterization of xenobiotic-induced hepatotoxicity,
screening of hepatoprotective effects of drugs, and studying
mechanisms of human liver injury [18, 19]. An ablation of the
SNS exerts a protective effect against CCl
4
induced acute liver
injury in mice [20]. In the current study peripheral injection
of the neurotoxin 6-hydroxydopamine hydrobromide (6-
OHDA) was used to induce chemical sympathectomy and
the effects on acute CCl
4
induced hepatic lipid peroxidation
were assessed. We also tested the hypothesis that adrenergic
signaling is required for control of the oxidative stress
in hepatocytes after acute CCl
4
exposure. The observation
that chemical sympathectomy or treatment with the 𝛼-
adrenoreceptor antagonist has profound inhibitory effects
on CCl
4
induced hepatic oxidative injury has important
implications for understanding of how the response to liver
injury may be controlled and, on a clinically applicable basis,
indicate potential novel strategies for management of acute
or, indeed, chronic liver injury.
2. Materials and Methods
2.1. Animal Care. Male C57Bl/6JNarl mice aged 8 weeks
were obtained from the National Laboratory Animal Center
in Taipei, Taiwan. They were maintained under controlled
conditions (22 ± 1∘C and 12 h day/night rhythm) and fed
standard laboratory food.
2.2. Chemical Sympathectomy and Antagonists. Mice were
intraperitoneally injected with 100mg kg−1 6-OHDA (Sigma,
St. Louis, MO, USA) in 0.1% ascorbic acid (Sigma) in
phosphate buffered saline (PBS, Gibco, Gaithersburg, MD)
daily over 5 consecutive days. Peripheral administration of 6-
OHDA results in a “chemical sympathectomy” by depleting
sympathetic fibers [20] and has previously been found to
induce an 85% decrease in norepinephrine levels in the
liver [21]. Control mice received injections of 0.1% ascorbic
acid in PBS. One day following the final treatment with
6-OHDA, mice were subjected to the acute oxidative liver
injury protocol described below. Phentolamine (10mg kg−1)
and nadolol (20mg kg−1) were injected in 0.9% saline daily
intraperitoneally, commencing 5 days before CCl
4
adminis-
tration, while control mice were injected with 0.9% saline
vehicle.
2.3. Acute Oxidative Liver Injury Induced by CCl4. Mice were
injected intraperitoneally with a single dose of CCl
4
(Sigma)
(12.5% in olive oil (Sigma), 2mL kg−1). Control groups were
treated with vehicle (2mL kg−1 of olive oil). At 24 h after CCl
4
or vehicle treatment, mice were weighed and then euthanized
by carbon dioxide asphyxiation. Blood was collected from
the heart for analysis of serum AST, ALT, LDH, and ALP by
standard enzymatic methods. The liver was then removed,
weighed, and processed for further analysis as described.
2.4. Immunostaining and Assessment of Hepatocyte Nuclear
Morphology. Samples of liver from mice with or without
chemical sympathectomy were embedded in optimum cut-
ting temperature (OCT) (Tissue-Tek, Sakura, CA,USA) com-
pound and quickly frozen. Five 𝜇m thick sections were cut
and fixedwithmethanol/acetone. Immunohistochemistry for
identification of sympathetic nerve fibers was performed
with a primary antibody against tyrosine hydroxylase (the
key enzyme for norepinephrine production in sympathetic
nerve endings, Millipore, Billerica, MA, USA) and an Alexa
488 conjugated secondary antibody (against rabbit IgG,
Invitrogen Corporation, Carlsbad, CA, USA). Following a
final incubation for 1 h with propidium iodide (50𝜇g/mL)
(Invitrogen) sections were viewed with a Zeiss LSM 510 Meta
inverted confocalmicroscope using a LD-Achroplan 20x lens.
For assessment of nuclear morphology sections were
washed twice in TBST (12.5mM Tris/HCl, pH 7.6, 137mM
NaCl, and 0.1% Tween 20) before 4󸀠,6-diamidino-2-phenyl-
indole dihydrochloride (DAPI) (Sigma) diluted 1 : 10,000 in
PBS for 5min at room temperature. Slidesweremountedwith
glycerin, coverslipped, and examined using a fluorescence
microscope (Olympus BX-51).
2.5. Histological Analysis of the Liver. The liver left lateral
lobeswere removed and fixed in 10%buffered formalin before
standard tissue processing, embedding in paraffin wax, and
cutting into 5 𝜇m sections which were stained with hema-
toxylin and eosin. Histological examination was performed
in a blinded fashion by three experienced pathologists. The
severity of hepatic injurywas scored as described byCamargo
et al. [22] according to the following criteria: 0, minimal
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or no evidence of injury; 1, mild injury with cytoplasmic
vacuolization and focal nuclear pyknosis; 2, moderate to
severe injury with extensive nuclear pyknosis, cytoplasmic
hypereosinophilia, and loss of intercellular borders; and 3,
severe necrosis with disintegration of hepatic cords, hem-
orrhage, and neutrophil infiltration. Areas of hepatocyte
necrosis were expressed as the percentage of damaged liver
architecture, measured in 10 randomly selected high-power
fields per section using ImageJ software (version 1.48u, US
National Institutes of Health).
2.6. Estimation of Hepatic Lipid Peroxidation Assay. Samples
of liver were homogenized on ice in PBS containing butyl-
hydroxytoluene and centrifuged at 10,000 g (4∘C, 5min). 4-
HNE adducts were measured in supernatants with the OxiS-
elect HNE-His adduct enzyme-linked immunosorbent assay
(ELISA) kit (Cell Biolabs, Inc., San Diego, CA) in accordance
with themanufacturers’ instructions.The concentration of 4-
HNE adducts was normalized permicrogramof total protein,
the concentration of the latter being determined by the Lowry
method.
2.7. Transmission Electron Microscopy. Liver tissues were
fixed in a mixture of 4% paraformaldehyde and 0.5% glu-
taraldehyde in PBS, pH 7.4, and prepared routinely for
transmission electron microscopy with final embedding in
LR white resin. Ultrathin sections (70–80 nm) were cut,
placed on a nickel grid, and then examined under a Hitachi
H-600 transmission electron microscope.
2.8. 8-Hydroxy-2-deoxyguanosine (8-OHdG)Assay. TotalDNA
from liver was extracted using the Qiagen DNeasy blood
and tissue kit according to the manufacturer’s instructions
(Qiagen, Valencia, CA, USA). ANanoDrop 1000 spectropho-
tometer (Thermo Fisher, Pittsburgh, PA, USA) was utilized to
measureDNApurity. Briefly, pHofDNA(25𝜇g)was adjusted
to 5.2 with 3M sodium acetate. The DNA reaction mixture
was subjected to 1 𝜇L of nuclease P1 (1 U/𝜇L) digestion for 2 h
at 37∘C.After 2 h of incubation, 15𝜇Lof 1MTris-HCl (pH8.0)
was used to bring the pH back to 7.4, followed by treatment
with 5 𝜇L of alkaline phosphatase (1 U/𝜇L stock) for 1 h. The
reaction mixture was centrifuged for 5min at 6,000 g, and
the supernatant was collected for the 8-OHdG assay using
theOxiSelect oxidative DNAdamage ELISA kit (Cell Biolabs,
Inc., San Diego, CA, USA) according to the manufacturer’s
instructions. Known standards were also included in the
assay to allow accurate quantitation. Six livers were used for
each experimental group.
2.9. Cytokines/Chemokines Antibody Array. Livers were
homogenized in lysis buffer (kit component) and then
centrifuged to collect the supernatant to detect 40 cytoki-
nes/chemokines on the RayBio Mouse Inflammation Anti-
body Array 1 membrane (RayBiotech, Inc., Norcross, GA,
USA), according to the manufacturer’s protocol. We pooled
six samples per group to obtain 300 𝜇g total proteins per
membrane (one membrane for each group). The membranes
were blocked in 2mL of blocking buffer for 30min and then
incubated with pooled supernatant at room temperature for
2 h. The samples were then decanted from each container,
and the membranes were washed three times with 2mL of
wash buffer I, followed by two washes with 2mL of 1x wash
buffer II at room temperature with shaking. The membranes
were incubated in 1 : 250-diluted biotin-conjugated primary
antibodies at room temperature for 2 h and washed as
above before incubation in 1 : 1000-diluted horseradish
peroxidase-conjugated streptavidin. After incubation in
horseradish peroxidase-conjugated streptavidin for 1 h, the
membranes were washed thoroughly and exposed to a
peroxidase substrate for 5min in the dark before imaging.The
membranes were scanned and analyzed by using TotalLab
Quant software (TotalLab Ltd., Newcastle upon Tyne, UK).
Proteins with >2-fold differences in their expression levels
between the saline + CCl
4
group and the saline + olive oil
group were considered as differentially expressed.
2.10. Statistical Analysis. The results were expressed as mean
± standard deviation (SD). Results were analyzed using
Student’s 𝑡-test for unpaired data. The statistical significance
level was a 𝑝 value of < 0.05.
3. Results
3.1. Alleviation Effect of Chemical Sympathectomy on Lipid
Peroxidation inCCl4 InducedHepatic Injury. Tyrosine hydro-
xylase-expressing fibers were readily identified in the border
of periportal areas of saline-treated mice but were essentially
absent in 6-OHDA-treated animals (Supplementary Data,
Figure S1 in Supplementary Material available online at
http://dx.doi.org/10.1155/2016/3190617) confirming success-
ful hepatic sympathectomy. There was no hepatic necrosis
in saline- or 6-OHDA-treated mice treated with olive oil
alone. The extent of CCl
4
induced hepatic necrosis was
significantly greater in saline-treated mice than in 6-OHDA-
treated mice (32.1 ± 8.6% versus 9.2 ± 4.4%, 𝑝 = 0.0007)
(Supplementary Data, Figures S2(a) and S2(b)). Similarly
the severity score of hepatic injury was significantly greater
(Supplementary Data, Figure S2(c), 𝑝 < 0.0001) in the
saline + CCl
4
group (2.7 ± 0.5) when compared to the 6-
OHDA+CCl
4
group (1.5±0.5). Biochemical markers of liver
injury, including aspartate aminotransferase (AST; 4,115 ±
1,755 versus 17, 830 ± 3, 078 IU/L, 𝑝 < 0.0001), alanine
aminotransferase (ALT; 7,809 ± 2,527 versus 15,519 ± 4,678,
𝑝 = 0.0052), alkaline phosphatase (ALP; 56± 26 versus 128±
11, 𝑝 = 0.0013), and lactate dehydrogenase (LDH; 11,139 ±
5,496 versus 28,764±8,063, 𝑝 = 0.0001) levels 24 h after CCl
4
treatment were lower in serum from 6-OHDA-treated mice
compared to the saline-treated group (Supplementary Data,
Table S1).
As secondary products during lipid peroxidation, mal-
ondialdehyde appears to be the most mutagenic product of
lipid peroxidation, whereas 4-HNE is the most toxic and
considered as “one of major generators of oxidative stress”
and a “major lipid peroxidation product” [23–25]. Thus,
we investigated ROS-induced lipid damage as measured by
changes in 4-HNE levels in the livers of saline- and 6-OHDA-
treated mice 24 h after CCl
4
administration (Table 1). As
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Table 1: Effect of sympathectomy on CCl
4
induced lipid peroxidation in liver.
Parameter Saline + olive oil(𝑛 = 6)
6-OHDA + olive oil
(𝑛 = 6)
Saline + CCl
4
(𝑛 = 6)
6-OHDA + CCl
4
(𝑛 = 6)
4-Hydroxy-2-nonenal (4-HNE, 𝜇g/𝜇g protein) 0.23 ± 0.02 0.18 ± 0.02∗∗ 0.33 ± 0.07∗ 0.23 ± 0.03##,††
The results are presented as mean ± SD.
∗ denotes significant differences compared with the saline + olive oil group (𝑝 < 0.05).
∗∗ denotes significant differences compared with the saline + olive oil group (𝑝 < 0.01).
## denotes significant differences compared with the saline + CCl4 group (𝑝 < 0.01).
†† denotes significant differences compared with the olive oil + 6-OHDA group (𝑝 < 0.001).
expected, 4-HNE was elevated in the livers of saline-treated
mice 24 h after CCl
4
treatment (𝑝 = 0.0122). This increase in
lipid peroxidation was blocked when mice were treated with
6-OHDA prior to CCl
4
(𝑝 = 0.0053).
3.2. Protective Effect of Chemical Sympathectomy on the Ultra-
structure of Hepatocyte Injury. Elevation in lipid peroxida-
tion levels has been reported to correlate with ultrastructural
changes in hepatocytes following CCl
4
exposure since 4-
HNE can promote organelle damage [25–27]. In the current
study the ultrastructure of hepatocytes was normal in the
olive oil-treated groups (Figures 1(a), 1(b), 1(e), and 1(f)).
Twenty-four hours after CCl
4
administration, ultrastructural
changes including expansion of the perinuclear space with
a pyknotic condensed nucleus, increased number and size
of lipid globules, glycogen loss, and mitochondrial swelling
with loss of cristae in addition to dilation of the cisternae of
rough endoplasmic reticulum were evident (Figures 1(c) and
1(g)). In comparison to the saline + CCl
4
mice, the number
and size of lipid globules were decreased and glycogen
deposits were readily identifiable within hepatocytes in the 6-
OHDA+CCl
4
group. Similarly the organelle and cytoplasmic
structures appeared preserved from the deleterious effects of
CCl
4
(Figures 1(d) and 1(h)).
3.3. Attenuation Effect of Chemical Sympathectomy onHepatic
Nuclear Damage. Lipid peroxidation products, in particular,
4-HNE, are known to promote hepatocyte nuclear loss or
injury [24, 27, 28] which can be visualized by DAPI staining
[29].The nuclei in hepatocytes of olive oil alone-treated mice
were round and emitted even blue fluorescence (Figure 2). In
the necrotic pericentral region livers of saline-treated mice
24 h afterCCl
4
administration nuclei were absent, condensed,
or fragmented. 6-OHDA effectively preserved the integrity
and morphology of hepatic nuclei in CCl
4
-treated mice
(Figure 2).
3.4. Inhibition Action of Chemical Sympathectomy on Oxida-
tive DNA Damage in Liver. Since 4-HNE also has high
capability of reaction with DNA to cause DNA damage [25,
30], we examined whether sympathectomy attenuates liver
oxidative DNA damage by analyzing 8-OHdG content in
hepatocyte. The level of 8-OHdG in CCl
4
-treated livers with-
out sympathectomy was increased by 94% when compared
with that in olive oil-treated livers without sympathectomy
(Figure 3, 𝑝 = 0.0092). Pretreatment with 6-OHDA, on the
other hand, abrogated this increase (𝑝 = 0.0113). There
was no significant difference in levels of 8-OHdG between
the 6-OHDA + olive oil group and saline + olive oil group
(Figure 3).
3.5. Analysis of Cytokine and Chemokine Protein Profiling in
Livers. It is known that 4-HNE plays a role as mediator of
inflammatory processes with interactions with the cytokine
networks [31–33]. In the current study we investigated the
inflammatory response using a multiplex of 40 cytokines and
chemokines. The results are shown in Figure 4. Following
administration of CCl
4
there was increased expression of a
number of cytokines including IL-1𝛼 (2.28-fold, 𝑝 = 0.0192),
IL-10 (3.64-fold, 𝑝 = 0.0070), leptin (9.27-fold, 𝑝 = 0.0496),
tissue inhibitor of metalloproteinase-2 (TIMP-2, 2.90-fold,
𝑝 = 0.0087), soluble tumor necrosis factor receptor I (sTNFR
I, 3.62-fold, 𝑝 = 0.0228), and granulocyte-macrophage
colony-stimulating factor (GM-CSF, 5.58-fold, 𝑝 = 0.0019).
There was also an increase in expression of 5 inflammation-
associated chemokines. These were CCL3 (3.80-fold, 𝑝 =
0.0243), CCL5 (2.42-fold, 𝑝 = 0.0153), CCL9 (3.57-fold,
𝑝 = 0.0064), CCL11 (3.79-fold, 𝑝 = 0.0344), and CXCL11
(6.71-fold, 𝑝 = 0.0057). With chemical sympathectomy, in
the absence of CCl
4
, there was reduction of protein levels
of CCL5 (0.66-fold, 𝑝 = 0.0022) and CCL9 (0.54-fold, 𝑝 =
0.0083) when compared with the saline + olive oil group
but no significant change in the levels of other cytokines
and chemokines was evident. Pretreatment with 6-OHDA
inhibited the increase in hepatic cytokine and chemokine
levels induced by CCl
4
.
3.6. Hepatoprotective and Antioxidant Effects of 𝛼-Adrenergic
Blockade against CCl4 Induced Oxidative Damage. Our
findings strongly implicate an important role for the SNS
in modulating CCl
4
induced oxidative stress in liver,
based strictly on 6-OHDA ablation of the peripheral SNS.
However, it is unclear whether 6-OHDA could affect other
cell types, for example, hepatocytes, in mice and through an
alternative route directly or indirectly affect oxidative stress
or the hepatic antioxidant status. To address this concern,
we treated mice with drugs that selectively block 𝛼- or
𝛽-adrenergic receptors. Phentolamine, an 𝛼-blocker, and
nadolol, a 𝛽-blocker, were delivered intraperitoneally over
5 consecutive days before injection with CCl
4
. Nadolol had
no significant effect on hepatic injury and antioxidant status
(Table 2), indicating that 𝛽-adrenergic stimulation may not
enhance or suppress hepatic oxidative stress responses to
CCl
4
. Strikingly, phentolamine enhanced antioxidant status
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Figure 1: Effect of 6-OHDA on CCl
4
induced changes on hepatocyte morphology. Representative micrographs of transmission electron
microscopy (magnification 6,000x or 12,000x) in the liver tissues. (a and e) The saline + olive oil group; (b and f) the 6-OHDA + olive oil
group; (c and g) the saline + CCl
4
group; and (d and h) the 6-OHDA+CCl
4
group. Arrows denote rough endoplasmic reticulum. Arrowheads
denote perinuclear space. C, chromatin; G, glycogen deposits; L, lipid drops; Vac, vacuolization. Scale bar denotes 100 nm in (a)–(d) and
500 nm in (e)–(h).
Table 2: Hepatic lipid peroxidation and serum biochemical markers in mice after 24 hours of CCl
4
treatment with or without pretreatment
of 𝛼-adrenergic blocker or 𝛽-adrenergic blocker.
Parameter Saline + CCl4(𝑛 = 4)
Phentolamine + CCl
4
(𝑛 = 4)
Nadolol + CCl
4
(𝑛 = 4)
4-Hydroxy-2-nonenal (4-HNE, 𝜇g/𝜇g protein) 0.34 ± 0.04 0.25 ± 0.01∗ 0.28 ± 0.02
Aspartate transaminase (AST, IU/L) 16,695 ± 5,203 6,038 ± 3,320∗ 13,571 ± 5,758
Alanine transaminase (ALT, IU/L) 14,559 ± 3,268 7,318 ± 3,799∗ 10,830 ± 4,381
Alkaline phosphatase (ALP, IU/L) 131 ± 14 106 ± 21∗ 140 ± 31
Lactate dehydrogenase (LDH, IU/L) 30,656 ± 9,387 8,994 ± 5,986∗ 17,483 ± 10,584
The results are presented as mean ± SD.
∗ denotes significant differences compared with the saline + CCl4 group (𝑝 < 0.05).
in liver (Table 2, 𝑝 = 0.0238) and suppressed both the extent
of hepatic necrosis (11.62 ± 2.76% versus 27.55 ± 12.60%,
𝑝 = 0.0009) (Figure 5) and serum levels of AST (𝑝 = 0.0478),
ALT (𝑝 = 0.0387), ALP (𝑝 = 0.0346), and LDH (𝑝 = 0.0247)
(Table 2) following CCl
4
administration. Pretreatment with
phentolamine abrogated the increased level of 8-OHdG in
CCl
4
-treated livers (𝑝 = 0.0193). There was no significant
difference in levels of 8-OHdG between the nadolol + CCl
4
group and saline + CCl
4
group (Figure 5(c)). The magnitude
of the effect was similar to that induced by 6-OHDA
treatment, pointing to an important role in SNS activation
of 𝛼-adrenergic receptors in regulating antioxidant status in
liver.
4. Discussion
In the current study we show that the SNS has major roles
in regulating lipid peroxidation, oxidative DNA damage, and
proinflammatory cytokine production in the liver associated
with CCl
4
toxicity with chemical sympathectomy essentially
preventing the major hepatotoxic effects seen within 24 h
of CCl
4
administration. We also present that 𝛼-adrenergic
signaling is required for control of the oxidative stress in
hepatocytes after acute CCl
4
exposure.
The changes of hepatocyte ultrastructure identified in the
current study following CCl
4
administration are in line with
previous observations [26] and are likely to be the result of
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Figure 2: Effect of 6-OHDA on CCl
4
induced changes in hepatocyte nuclei. Representative micrographs of DAPI stained nuclei
(magnification 200x or 400x) in the liver tissues. Typical images were selected from each experimental group (original magnification 200x or
400x). Scale bar = 100 𝜇m in 200x and 50 𝜇m in 400x.
damage to cellular and organelle membrane structure caused
by lipid peroxidation [25, 27]. As chemical sympathectomy
prevents these changes it is probable that sympathectomy
supports the antioxidant defense system, maintaining mem-
brane integrity. Sympathectomy also attenuated CCl
4
toxicity
characterized by the appearance of dysfunctional hepatic
nuclei which arise as a result of enhanced lipid peroxidation
[24, 27, 28] further supporting the idea that the mode of
action of the beneficial effect of sympathectomy is through
reducing oxidative stress. Similarly, the observation that 6-
OHDA treatment inhibited oxidative stress-mediated DNA
damage in CCl
4
-treated mice suggests that sympathectomy,
at least in part, may attenuate oxidative stress-induced DNA
damage through the inhibition of lipid peroxidation and the
reduction of 4-HNE generation because 4-HNE is biologi-
cally reactive and known to cause DNA damage [25, 30].
The cytokine/chemokine array data also demonstrate
an inhibitory effect of chemical sympathectomy on CCl
4
induced hepatic proinflammatory responses. CCl
4
induced
production of inflammation-associated cytokines (IL-1𝛼, IL-
10, leptin, TIMP-2, and sTNFR I) in the liver, in part a
consequence of combined lipid peroxidation [31–33] and
hepatocyte necrosis [34], results in an immunostimulatory
environment [16, 35, 36]. Presumably the inhibitory effects
of sympathectomy on CCl
4
induced liver cell damage were
sufficient to prevent activation of inflammatory cascades. It
may also be possible that the SNS has a direct regulatory effect
on resident Kupffer [37] and stellate cells [38] within the liver.
We also identified an effect of sympathectomy on elevation
of hepatic leptin following CCl
4
induced injury. There is
increasing evidence that leptin augments inflammatory and
profibrogenic responses to hepatic injury [39, 40] whilst
downregulation of leptin decreases liver fibrosis [40, 41].
Sympathectomy appears therefore to potentially have both
protective anti-inflammatory and potentially antifibrogenic
effects.
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Figure 3: Effect of 6-OHDA on CCl
4
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significant differences (𝑝 < 0.01) compared with the saline + olive oil group. # denotes significant differences (𝑝 < 0.05) compared with the
saline + CCl
4
group.
CCl
4
also induced or upregulated the protein expres-
sion levels of 5 inflammation-associated chemokines (CCL3,
CCL5, CCL9, CCL11, and CXCL11), a response inhibited
by pretreatment with 6-OHDA. Increased expression of
CCL3 and CCL5 following CCl
4
treatment is consistent with
previous studies [42, 43]. To the best of our knowledge,
this is the first demonstration of expression of CCL9, a
mouse CC chemokine and strong chemoattractant for bone
marrow cells [44], in liver. CCL11 is a known potent inducer
of eosinophil chemotaxis and regulates the recruitment to
the liver after CC1
4
induced hepatic injury to facilitate liver
regeneration [45]. CXCL11 release has previously been shown
to be induced by oxidative stress exposure [46] and liver
ischemia/reperfusion injury [47] supporting the idea that the
antioxidant effect of sympathectomy is possibly attributable
to the downregulation of CXCL11 and possibly the other
cytokines and chemokines studied including GM-CSF [48].
Studies describing an interaction with pharmacological
sympathetic blockade have been reported for CCl
4
. Pretreat-
ment with either prazosin, an 𝛼
1
-selective adrenoreceptor
antagonist, or yohimbine, an 𝛼
2
-selective adrenoreceptor
antagonist, abolishesmethamphetamine potentiation of CCl
4
hepatotoxicity. However, neither prazosin nor yohimbine has
any effects on toxicity produced by CC1
4
alone [5, 49]. The
ability of phenoxybenzamine, a nonselective, irreversible 𝛼-
adrenergic receptor antagonist, to counteract the hepatotoxic
effect ofCCl
4
by preventing the action of catecholamines [50],
has been reported. A similar observation was noticed in the
recent study of the interaction between dopaminergic agonist
piribedil and CCl
4
. Administration of piribedil results in
amelioration ofCCl
4
induced liver damage probably due to its
𝛼
2
-adrenoceptor antagonist properties to reduce sympathetic
outflow and then decrease the extent of lipid peroxidation
[51]. Since both phenoxybenzamine and piribedil cross the
blood-brain barrier, they would be expected to antagonize
pan 𝛼- or 𝛼
2
-adrenoreceptors, respectively, within the central
nervous system (CNS). Our findings that phentolamine, a
pan 𝛼-adrenergic antagonist which has no access to the CNS,
suppresses hepatic injury through oxidative stress suggest
that suppression of antioxidant status by SNS is associated
with the peripheral release of catecholamines. Moreover,
we show that it is unlikely that the 𝛽-adrenergic signaling
modulates CCl
4
induced oxidative stress by pretreatment
with nadolol. This observation appears to be consistent with
a role for isoproterenol, an agonist at both 𝛽
1
- and 𝛽
2
-
adrenoreceptors, found to have no effect on potentiation of
CCl
4
induced hepatotoxicity [52] and may be due to the con-
cept that 𝛽-receptor activation decreases H
2
O
2
synthesis in
hepatocyte plasmamembrane [53, 54]. Althoughwe favor the
idea that the𝛼-blocker acts directly on hepatocytes we cannot
eliminate the potential contribution of catecholamines on
bloodflow to liver. Activation of the SNS results in production
of both “classical” neurotransmitters norepinephrine and
epinephrine and cotransmitters such as adenosine triphos-
phate and adenosine. Hepatocytes express various adrenergic
and purinergic receptors that are sensitive to thesemolecules,
and the production of cytokines/chemokines is probably
modulated by activation of these receptors [1, 55] and not
necessarily by adrenergic activity alone.
5. Conclusions
In conclusion, we found that sympathectomy or 𝛼-adrenergic
blockade decreased hepatic lipid peroxidation in CCl
4
induced liver injury.Our results also suggest that the SNSmay
regulate inflammatory cytokine and chemokine production
following hepatic injury through regulation of lipid peroxida-
tion.This study demonstrates that modulation of the SNS can
potentially influence the outcome of acute liver damage and
provides a basis to explore the effects of adrenergic modifiers
on treatment of drug-induced liver injury in humans.
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Figure 4: Effect of 6-OHDA on levels of hepatic cytokines and chemokines in the absence and following CCl
4
treatment. (a) A cytokine array
assay in the liver of the saline + olive oil group, the 6-OHDA + olive oil group, the saline + CCl
4
group, and the 6-OHDA + CCl
4
group was
measured. Altered cytokines (twofold or more), including IL-1𝛼, IL-10, leptin, TIMP-2, sTNFR I, GM-CSF, CCL3, CCL5, CCL9, CCL11, and
CXCL11, are indicated by boxes. (b)The relative density of cytokines and chemokines was normalized with the internal control and expressed
as a ratio of the expression level of cytokines and chemokines in each group divided by the expression level in the saline + olive oil group.
Each value represents the average of two replicated spots on the membrane. In all figures, ∗ denotes significant differences compared with
the saline + olive oil group (𝑝 < 0.05). ∗∗ denotes significant differences compared with the saline + olive oil group (𝑝 < 0.01). # denotes
significant differences compared with the saline + CCl
4
group (𝑝 < 0.05). ## denotes significant differences compared with the saline + CCl
4
group (𝑝 < 0.01).
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Figure 5: Effect of 𝛼- or 𝛽-adrenergic blocker on CCl
4
induced hepatic injury and oxidative DNA damage. Histological features (a) and
area of necrosis (b) of liver sections stained with hematoxylin and eosin 24 h after CCl
4
treatment. Typical images were selected from each
experimental group (original magnification 200x).The saline + CCl
4
group showing hepatocellular necrosis; the phentolamine + CCl
4
group
showing mild hepatocellular necrosis. (c) Oxidized DNA in liver was measured 24 hours after exposure to CCl
4
following pretreatment with
saline, phentolamine, or nadolol. Data plotted are mean and SD (𝑛 = 4 animals in each group). ∗ denotes significant differences (𝑝 < 0.05)
compared with the saline + CCl
4
group. ∗∗∗ denotes significant differences (𝑝 < 0.001) compared with the saline + CCl
4
group.
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